MetadataShow full item record
JournalPLoS Neglected Tropical Diseases
AbstractThe 2014-6 West African Ebola epidemic highlights the need for rigorous, rapid clinical trial methods for vaccines. A challenge for trial design is making sample size calculations based on incidence within the trial, total vaccine effect, and intracluster correlation, when these parameters are uncertain in the presence of indirect effects of vaccination.
PublisherPublic Library of Science
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
- Authors: Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé MK, Kone S, Kuisma E, Levine MM, Mandal S, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Watson CH, Kéïta S, Kieny MP, Røttingen JA
- Issue date: 2015 Aug 29
- Needle size for vaccination procedures in children and adolescents.
- Authors: Beirne PV, Hennessy S, Cadogan SL, Shiely F, Fitzgerald T, MacLeod F
- Issue date: 2015 Jun 18
- The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola.
- Authors: Ebola ça Suffit Ring Vaccination Trial Consortium.
- Issue date: 2015 Jul 27
- Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.
- Authors: Ali M, Debes AK, Luquero FJ, Kim DR, Park JY, Digilio L, Manna B, Kanungo S, Dutta S, Sur D, Bhattacharya SK, Sack DA
- Issue date: 2016 Sep
- Leveraging contact network structure in the design of cluster randomized trials.
- Authors: Harling G, Wang R, Onnela JP, De Gruttola V
- Issue date: 2017 Feb